Biotech

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.

 CEO and co-founder of Immunai Noam Solomon.
WORKERS TAKE care of cannabis plants at a farm in central Israel,  late last year.

Israeli researchers develop SafeWax coating that could cut pesticide use by 50%

 Heart hologram and doctor, heart disease. Health care of the future. Modern Medical Science, Hi Tech Diagnostic Panel. Mixed medium, copy space

Arkin raises $100m for early-stage biotech fund

Automated pharmaceutical conveyor line, robotic arms handling medical vials

Israel's biotech moment: How science, data, and geopolitics are converging - opinion


The unique challenges integrating AI into biotechnology - opinion

According to Start-Up Nation Central (SNC), AI represents about 30% of Israel’s start-ups and attracts nearly half of total company funding.

 Artificial Intelligence Illustration

Immunai and Teva partner to innovate new cancer, immunology therapies

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

 An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Aardvark tech track gives gap year students an opportunity to take part in the start up nation

The Inside Israeli Innovation Podcast with guest hosts Ellie Esquenazi and Corey Tusak: Season 2, Episode 34.

 Guests hosts Ellie Esquenazi and Corey Tusak

For the first time: The great women's conference of the Jerusalem hi-tech

First-ever "Women at the Front" conference in Jerusalem for 250 senior women in tech on Sept 22 at JVP complex. AI, career management, and more.

 Liron Dover, Director of Hi-Tech and Bio-Tech at the Jerusalem Development Authority

Achievement: Japanese pharma firm invests in Israeli cell startup

Japanese pharma company Astellas Venture Management invests in Israeli startup Somite AI, expanding pre-seed round with over $10 million in fundraising for innovative stem cell treatments using AI.

 The founders of Somite AI

Self-dyeing, plastic-free vegan leather can be grown from bacteria, study shows

Their new process could also theoretically be adapted to have bacteria grow materials with various patterns and vibrant colors and to make more sustainable alternatives to other textiles.

The self-dyeing vegan, plastic-free leather is  a step forward in the quest for more sustainable fashion. (Illustrative).

EmendoBio enters a licensing agreement for its gene editing technology with Anocca AB

 EmendoBio

AION Labs unveils TenAces start-up, will use AI to predict molecular glues

The company aims to improve the success rate of the discovery of treatments for a range of conditions.

 AION Labs participants work on their proposals ahead of their final presentations.

Israel’s cell-based coffee: Sustainable solution to brewing industry challenges?

Due to climate change, within the next two decades, there is an expected 50% reduction in areas suitable for growing coffee.

 Pluri's new cell-based coffee

Profuse Technology achieves 80% faster muscle growth for cultivated meat

A cultivated meat company has developed a new method for promoting muscle growth in the lab • the new technique enhances protein content by a factor of five, with tissue reaching maturity in just 48h

Profuse's 3D cultivated meat